Charles River Laboratories International, Inc. (crl)
CRL Earnings
Public earnings and growth snapshot for Charles River Laboratories International, Inc.. Full earnings calendars, surprises, and multi-year history are available in Vest Terminal.
| Earnings growth (YoY) | N/A |
| Revenue growth (YoY) | -2.7% |
| Trailing P/E | N/A |
| Forward P/E | 21.82 |
| Last price | $277.33 |
| Market cap | $13.36B |
Start Free — open CRL in Vest Terminal
Access live data, filings, ownership, and analysis for Charles River Laboratories International, Inc..
Charles River Laboratories International, Inc. FAQ
What does Charles River Laboratories International, Inc. (CRL) do?
Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. The Research Models and Services segment produces and sells rodents, and pur…
What is CRL's P/E ratio?
Charles River Laboratories International, Inc. has a trailing P/E of N/A× based on publicly available market data.
Does CRL pay a dividend?
Indicated dividend yield: none reported. Confirm ex-dates and payout history in Vest Terminal.
What sector is CRL in?
Charles River Laboratories International, Inc. is classified in Healthcare (Diagnostics & Research) on NYQ.
What is CRL's market capitalization?
Approximate market cap: $13.36B.
What are the main risks for CRL?
Key risks include above-average volatility (beta 1.41), negative revenue growth, among factors on this page.
What are the strengths of CRL?
Potential positives include positive free cash flow ($468.86m), large cap scale ($13.36b) may provide distribution and funding advantages.
Where can I get analyst estimates for CRL?
Public analyst price targets and consensus for Charles River Laboratories International, Inc. are on the free /stocks/crl/estimates page. Deeper estimate history and models are available in Vest Terminal.